» Articles » PMID: 18031257

Structure-function Relationships of Toll-like Receptor Domains Through Homology Modelling and Molecular Dynamics

Overview
Specialty Biochemistry
Date 2007 Nov 23
PMID 18031257
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

TLRs (Toll-like receptors) are pattern-recognition receptors of the immune system and recognize pathogens based on distinct molecular signatures. Although different TLRs within the same species (orthologues) or individual TLRs across different species (homologues) are similar in protein sequence, they differ considerably with regard to their function, for example with regard to ligand discrimination or adaptor selection. Owing to the lack of structural information, explanations for these phenomena have been difficult to provide. We have combined homology modelling with energy minimization and Molecular Dynamics simulation in order to address these interesting biological phenomena from a structural angle. Thus three-dimensional models of human and mouse TLR3 and TLR4 domains were successfully generated. Apart from providing a structural framework in which mutagenesis studies (both site-directed and random) can be interpreted and designed, Molecular Dynamics also allowed us to study and simulate protein structure under solution-like conditions. We have applied this approach to the human TLR3 and TLR4 ECDs (ectodomains) providing insights into the dynamics of TLR ECDs. Other conclusions drawn from our structural models are also discussed. We hope that our structural modelling approach, which can be extended to other members of the TLR family or other signal transduction pathways, will serve as a valuable tool for the design of experiments to address questions of TLR biology further.

Citing Articles

A Clinical Trial of Entolimod a TLR-5 Adjuvant for Vaccines Using Diphtheria or Tetanus as Carrier Proteins.

Kosten T, Domingo C, Haile C, Nielsen D Vaccines (Basel). 2022; 10(10).

PMID: 36298456 PMC: 9611255. DOI: 10.3390/vaccines10101592.


Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.

Wang X, Chen Y, Zhang S, Deng J PLoS One. 2022; 17(4):e0260565.

PMID: 35452465 PMC: 9032342. DOI: 10.1371/journal.pone.0260565.


The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling.

Palmer C, Peri F, Neumann F, Ahmad F, Leake D, Pirianov G Innate Immun. 2018; 24(7):411-421.

PMID: 30208782 PMC: 6830872. DOI: 10.1177/1753425918798904.


Computational Approaches to Toll-Like Receptor 4 Modulation.

Billod J, Lacetera A, Guzman-Caldentey J, Martin-Santamaria S Molecules. 2016; 21(8).

PMID: 27483231 PMC: 6274477. DOI: 10.3390/molecules21080994.


Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model.

Takanashi M, Sudo K, Ueda S, Ohno S, Yamada Y, Osakabe Y Mol Ther Nucleic Acids. 2015; 4:e258.

PMID: 26484944 PMC: 4881762. DOI: 10.1038/mtna.2015.34.